GenomeKey

GenomeKey enables targeted Sepsis treatment in hours, rather than days. This is important because Sepsis now kills more people than cancer. It can hit anyone, of any age, and kills within hours. A patient admitted to a hospital today, they wait 3 days before the doctor knows which antibiotic will fight the infection. We use cutting edge machine learning and DNA sequencing to bring 3 days down to just a few hours, with the only affordable test that provides a result for every patient. This saves lives, saves money, and saves our last antibiotics for when we really need them...

Machine learning,a.i.,bioinformatics,and microbiology

Genomekey operates in the Biotechnology industry.

Genomekey's revenue is 11m - 100m

Genomekey has 11 - 50 employees.